ArticleFrontiers in cardiovascular medicine2026
4D-Micro: a tiered, testable framework for hemodynamic-tissue perfusion mismatch in cardiac surgery.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Organ dysfunction can develop after cardiac surgery even when mean arterial pressure, cardiac output, hemoglobin, temperature, and pump flow meet conventional targets. These variables remain the safety foundation, but they do not directly establish exchange-capable capillary flow or cellular oxygen use. We propose 4D-Micro, an unvalidated conceptual framework organized around four necessary functions: barrier and conduit integrity, perfusion driving, hemorheology, and cellular oxygen use. The framework was formalized from a recurrent clinical reasoning problem through targeted evidence mapping and explicit construction rules; it was not derived from a new patient dataset or statistical latent-variable analysis. 4D-Micro separates where recovery is discordant from the provisional mechanism that might explain it, then uses a prespecified proximal response and stopping boundary to update that explanation. It is not a substitute for established cardiac surgical monitoring or a claim that all four domains can be measured directly at the bedside. A tiered implementation distinguishes a core mode based on routine variables, an enhanced mode using regional and congestion signals, and a research mode using direct microvascular or biomarker measurements. Insufficient or conflicting data remain indeterminate rather than being forced into a phenotype. We specify a staged validation pathway: content and feasibility testing, prospective assessment of classification reliability and construct validity, and only then a pragmatic comparison with protocolized usual hemodynamic care. The framework should be narrowed or rejected if it cannot be applied reliably, its predicted responses are not observed, or it fails to improve decision processes without added harm.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.